Cargando…
Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older
BACKGROUND: Older adults are given high priority for coronavirus disease 2019 (COVID-19) vaccination; however, little is known about the safety of vaccines. This study was conducted to examine the safety of the COVID-19 vaccine for people who were ≥ 75 years of age, specifically those who first took...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Medical Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608922/ https://www.ncbi.nlm.nih.gov/pubmed/34811980 http://dx.doi.org/10.3346/jkms.2021.36.e318 |